Skip to main content
Top

Breast Cancer Research

Issue 1/2003

Content (22 Articles)

Commentary

Models of breast cancer: is merging human and animal models the future?

Jong B Kim, Michael J O'Hare, Robert Stein

Open Access Research article

A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment

Mark E Robson, Pierre O Chappuis, Jaya Satagopan, Nora Wong, Jeff Boyd, John R Goffin, Clifford Hudis, David Roberge, Larry Norton, Louis R Bégin, Kenneth Offit, William D Foulkes

Open Access Research article

Interleukin-2 and its receptor complex (α, β and γ chains) in in situand infiltrative human breast cancer: an immunohistochemical comparative study

Ignacio García-Tuñón, Mónica Ricote, Antonio Ruiz, Benito Fraile, Ricardo Paniagua, Mar Royuela

Open Access Research article

Expression of androgen receptor and prostate-specific antigen in male breast carcinoma

Noman Kidwai, Yun Gong, Xiaoping Sun, Charuhas G Deshpande, Anjana V Yeldandi, M Sambasiva Rao, Sunil Badve

Open Access Research article

Prevention of mammary carcinogenesis by short-term estrogen and progestin treatments

Lakshmanaswamy Rajkumar, Raphael C Guzman, Jason Yang, Gudmundur Thordarson, Frank Talamantes, Satyabrata Nandi

Meeting report

8th Nottingham International Breast Cancer Conference, Nottingham, UK, 16–19 September 2003

Jane L Limer, Alicia T Parkes, Alison Waterworth, Claire E Murphy, Cathy R Tait, Caroline J Witton

Open Access Research article

Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer

Hiroko Yamashita, Mariko Nishio, Tatsuya Toyama, Hiroshi Sugiura, Zhenhuan Zhang, Shunzo Kobayashi, Hirotaka Iwase

Commentary

Akt2: a role in breast cancer metastasis

Noan-Minh Chau, Margaret Ashcroft

Open Access Research article

Basic fibroblast growth factor and vascular endothelial growth factor serum levels in breast cancer patients and healthy women: useful as diagnostic tools?

Anna Maria Granato, Oriana Nanni, Fabio Falcini, Secondo Folli, Gabriella Mosconi, Franca De Paola, Laura Medri, Dino Amadori, Annalisa Volpi

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine